American Peptides: the retatrutide vial that became AP-RTA-3 after Eli Lilly sued
americanpeptides.usscored on 12 of 12 criteria
Be the first. The form below takes about twenty seconds and needs no account.
The score above weighs both: ours is what the record shows, theirs is what people who dealt with this entity say.
-
Is there an identifiable legal operator: a registered name, a jurisdiction, an address that resolves?
the site gives a Shreveport street address and the same address is in Lilly's complaint; the LLC and its Wyoming filing are known only from the complaint; the first storefront gave a placeholder phone number
-
Does it publish third-party certificates of analysis for what it sells?
lot-numbered certificates for each product from one named lab, Bioviridian Inc., whose site says ISO 17025 is in progress; the lab's own copies of both retatrutide certificates carry a later date and a sterility row the store's copies lack, with lot and results unchanged
-
Does it say what the legal status of what it sells is, honestly, where it ships?
research use only on an unapproved drug that it renamed and kept selling after the suit; in vitro on the gate, in vivo on the About page; clinics and compounding pharmacies invited as wholesale buyers
- Operating since
- at least 2026-02-21 (the domain was registered 2026-02-21; Lilly says the LLC was organized 2026-02-23; first archived storefront 2026-03-30)
- Where
- a shipping facility at 9742 St. Vincent Ave, Shreveport, Louisiana (the contact page, archived October 2026); a Louisiana-based LLC organized under Wyoming law (Eli Lilly's complaint, para 11)
- Presence
- @americanpep5
- Verified
- every quotation checked against its document on 2026-11-18; 30 sources
What they sell, and what we think is in it
- AP-RTA-3™ (formerly RETATRUTIDE (RETA), RETA-GLP3, AP-TRA3™) Peptides
Our best-selling triple-agonist research standard (LY3437943)
Retatrutide - AP-TRZ-2™ (formerly TIRZEPATIDE, TIRZ-GLP2, AP-DRA2™) Peptides
AP-TRZ-2
Tirzepatide - AP-SEM-1™ (formerly SEMA-GLP1, AP-GLR1™) Peptides
AP-SEM-1
Semaglutide - AP-MX4™ (formerly RETA-GLP3 + CAGRILINTIDE) Peptides
RETA-GLP3 + CAGRILINTIDE
Retatrutide with cagrilintide, an investigational amylin analogue - AP-AMR1™ (formerly CAGRILINTIDE) Peptides
AP-AMR1
cagrilintide, an investigational amylin analogue - AP-TESA™ (formerly TESAMORELIN) Peptides
AP-TESA
tesamorelin, a growth-hormone-releasing hormone analogue sold as a prescription drug - BPC-157 and blends (Wolverine, GLOW, KLOW) Peptides
BPC-157 + TB-500 (Wolverine Blend)
BPC-157 with TB-500, GHK-Cu and KPV in the blends - Liquid sprays and dissolving strips (Selank, Semax and others) Nootropics
SELANK LIQUID SPRAY
SelankSemax - Reconstitution solution Other
RECONSTITUTION SOLUTION 30 ML
a solvent for dissolving the powders
Molecules named in this dossier
- BPC-157 sells
- Retatrutide sells
- Selank sells
- Semaglutide sells
- Semax sells
- Tirzepatide sells
Pulse what people say about American Peptides
One tap, no account. Then for up to 36 Methyls.
The long read
Who they say they are, and what the record says
American Peptides sells peptides from a website at americanpeptides.us. The domain was registered on 21 February 2026.[1] The first storefront, archived in April, said "USA-Based Operations" and gave no address. Its footer phone number was "1-800-555-1234", a placeholder.[2] Its About page described the founders as "a father-son team with a shared vision" with "decades of experience in the medical and testing industry".[3]
By October the site named a city and a street. The contact page lists a "Shipping Facility" at "9742 St. Vincent Ave" in Shreveport, Louisiana.[4] The page promises "Orders placed before 2PM EST ship the same business day."[4] The footer says "Shreveport, LA",[5] and the home page says "Ships from Louisiana".[6] The site gives no company name beyond "American Peptides".
Eli Lilly and Company's complaint names the company behind it. These facts are Lilly's: it sued "Defendant American Peptides LLC, doing business as American Peptides", a "Louisiana-based limited liability company" "organized under the laws of Wyoming with its principal place of business at 9742 St. Vincent" Avenue, Shreveport. According to Lilly, the company was "organized on February 23, 2026 through organizer" a person the complaint names, under Wyoming filing ID 2026-001901875, two days after the domain was registered. "Its registered agent is Republic Registered Agent LLC", in Casper, Wyoming. The company also advertises on TikTok as @americanpep5, which describes it as "USA | Family Built".[7] The address on the site and the address in the complaint are the same.
What they sell
The catalogue is research peptides, blends such as "BPC-157 + TB-500 (Wolverine Blend)", nasal sprays such as "SELANK LIQUID SPRAY", dissolving strips and lab supplies.[6] This dossier is about the part Lilly sued over: retatrutide, Lilly's investigational weight-loss drug, which no regulator has approved. The store also sells tirzepatide, the active ingredient of Lilly's Mounjaro and Zepbound, and semaglutide, the active ingredient of Novo Nordisk's Ozempic and Wegovy.
Retatrutide, by four names. In April 2026 the best-sellers list on the home page began with "RETATRUTIDE (RETA)" and included "TIRZEPATIDE".[2] The vial in the banner was labelled RETA 10 MG.

Figure 1. The home page on 7 April 2026, about six weeks after the domain was registered. The vial on the right is labelled RETA 10 MG.[2]
By 6 October the product had become "RETA-GLP3", featured as the store's "#1 Research Peptide": "Our best-selling triple-agonist research peptide". Tirzepatide was "TIRZ-GLP2" and semaglutide "SEMA-GLP1", and a blend was sold as "RETA-GLP3 + CAGRILINTIDE".[8] The vial in the picture still read RETATRUTIDE. The site's footer already carried a note that "some of our product names may have recently changed".[8]

Figure 2. 6 October 2026, two days before the suit: the #1 product is called RETA-GLP3 and the vial reads RETATRUTIDE.[8]
Lilly filed suit on 8 October.[7] The archive caught the home page again on 9 October. The #1 product was now "AP-TRA3", tirzepatide "AP-DRA2", semaglutide "AP-GLR1", cagrilintide "AP-AMR1" and the blend "AP-MX4". The description changed one word, peptide to standard, and added Lilly's development code: "Our best-selling triple-agonist research standard (LY3437943)".[9] The price, from $105, did not change, and the vial in the picture still read RETATRUTIDE.

Figure 3. 9 October 2026, the day after the suit was filed: the name is AP-TRA3™ and the description now gives Lilly's development code, LY3437943. The vial still reads RETATRUTIDE. The price has not changed.[9]
Two days later the names changed again: by 11 October the #1 product was "AP-RTA-3".[10] On 3 November it was still "AP-RTA-3", next to "AP-TRZ-2" and "AP-SEM-1", with the same description and price. Tesamorelin, a prescription growth-hormone drug the store had sold under its own name, had become "AP-TESA". This time the vial label was redrawn to read AP-RTA-3.[6] The certificates on the same page are still filed under retatrutide lot numbers, such as "Lot RETA10-0803".[6]

Figure 4. 3 November 2026: the name is AP-RTA-3™, and the vial label has been redrawn to match. Same description, same price, still the #1 product.[6]
So the product was renamed, not removed. Every copy of the home page we read, five from April to November, features retatrutide under one name or another, and the latest, of 3 November, still sells it.
Where it is made. The site has told this two ways. In April the About page said: "Our raw peptides are sourced from" "advanced, high-quality manufacturing facilities abroad", and "All final processing, quality control, and packaging are handled in the United States".[3] By October the About page said "Manufactured + shipped domestically".[5] The wholesale page says "One U.S. lab. No mystery middlemen." and "Every peptide is synthesized in the same third-party-tested facility we own the relationship with."[11] None of these pages names the facility.
Who it sells to. Next to the research-use language, the store sells the supplies for injection. The October catalogue lists "RECONSTITUTION SOLUTION 30 ML".[6] According to Lilly, "once a purchaser selects retatrutide, the website auto-selects as a" required product a reconstitution solution, telling buyers they "need bacteriostatic water and a syringe to" reconstitute.[7] The tracker of Lilly's suits shows the checkout panel from the complaint. The wholesale page offers a tier for "Clinics & compounding pharmacies" and "Co-branded / private-label options".[11]
Affiliates. In April the home page already invited visitors to "Earn up to 35% commission promoting premium research peptides".[2] By October the partner programme calls itself "The highest-paying affiliate program in research peptides". Commission runs up to 35% "for the life of the customer", and a link builder is pitched as "It turns a DM into a one-tap sale".[12] Lilly's complaint calls it "The American Protocol Partner Program", whose pitch is to get paid to share "something you actually believe in". The complaint quotes an affiliate who, challenged on FDA approval, replied: "Weird because I sell to all the doctors, medspas, clinics loll."[7] We give the affiliates' descriptions and not their names: they are not parties.
What buyers report
On 18 November 2026 we searched the Arctic Shift archive of r/Peptides (18,427 posts since 1 September 2025) and r/Retatrutide (20,000 posts since 7 June 2026) for the store's name. Ten threads name it.[13] Three were removed and cannot be read. Two are questions from people who had not bought.
- Orders received. In August a buyer wrote "i just got reta 60mg vial from american peptides" and asked how much to inject.[14] In October a poster who wrote "i am a hospitalist" said "i just bought from american peptides and it seems legit", on the first day of use.[15]
- Complaints. In a September thread asking about the store, where the poster wrote that "the prices are crazy low which causes a fairly large amount of fear", one commenter replied "i ordered some it was rubbish used one vial and it didn" work.[16] Another poster relayed that "some are saying the retatrutide is fake", without an order of their own.[17] We count the first as a complaint and not the second.
- After the suit. On 15 November a reader wrote "i just ordered 30mg vial of ap rta 3 from american peptides", which they called "their research version of retatrutide", and asked how to get a "starter dose into my body".[18] That is one buyer's account, not a finding about the product. It shows the renamed product being bought for a person a month after the suit.
No thread reports an order that never arrived, and none reports harm. Ten threads is a small sample.
Lab results
The store publishes a certificate for each lot on its certificates page, with older lots marked "superseded".[19] The certificates we read are all from one laboratory, Bioviridian Inc., and none states an accreditation.
- Retatrutide, 48 mg, lot RETA48-0616. Certificate COA5633, issued 25 June 2026, identifies retatrutide by mass spectrometry and reports 48.16 mg at 99.9% purity, with endotoxin and heavy metals below their limits. The vial in the photo is labelled RETATRUTIDE 48MG and carries a sample sticker, QC263132, which is the sample number printed on the chromatogram.[20]
- Retatrutide, 10 mg, lot RETA10-0803. Certificate COA7580, issued 17 August 2026, reports 10.61 mg at 99.83% purity.[21] This is the lot the home page still links on 3 November.[6]
- AOD-9604, 5 mg, lot AOD5-0318. Certificate COA3362, issued 3 April 2026, reports 5.54 mg at 99.7%.[22] The store's logo appears inside the chromatogram's plot area. The certificate does not say why.

Figure 5. Bioviridian's June 2026 certificate for a 48 mg retatrutide vial: 48.16 mg found, within 1% of the label. The sample number on the vial, QC263132, is the one printed on the chromatogram.[20]
All three find the labelled amount or slightly more. The retatrutide certificates name the compound as retatrutide, whatever the product is called on the shop.
The laboratory's own copies. Every certificate points to a Bioviridian portal that asks visitors to "Enter the COA number from your results email to view, download or print your Certificate of Analysis."[23] On 18 November 2026 we looked up the three numbers above. The AOD-9604 certificate, COA3362, is byte for byte the file the store posted.[24] The two retatrutide certificates are not the store's copies:
- COA5633. The laboratory's copy is dated 7 July 2026, not 25 June. It adds a sterility result, not detected, that the store's copy lacks, and it puts the store's logo over the chromatogram.[25][20]
- COA7580. The laboratory's copy is dated 28 August, not 17 August. It also adds the sterility result, and it names the sample Retatrutide 100mg where the store's copy says Retatrutide 10mg. It reports the same 10.61 mg for the same lot.[26][21]
On both, the lot number, the amount found, the purity and the chromatograms are the same as on the store's copies. The documents do not say why the versions differ. A laboratory may reissue a certificate after adding a test. Bioviridian's services page says "ISO 17025 in Progress": the laboratory does not yet claim that accreditation.[27]
The same laboratory signs certificates for Cenexa Labs, another seller Lilly sued on the same day. A shared testing lab is common among peptide sellers, and on its own it connects nothing else. We have no independent test of an American Peptides product.
Regulatory and legal
Eli Lilly and Company v. American Peptides LLC, No. 5:26-cv-04146 (W.D. La.). Lilly sued on 8 October 2026.[7] The case is one of the eleven in our tracker of Lilly's retatrutide suits, which covers the legal theory. The claims are under state unfair-competition and consumer-protection law, and the complaint concludes that the store "markets and sells its purported retatrutide products for human consumption". Lilly's points, none tested in court:
- The product. The store listed retatrutide as its "#1 Research Peptide" and "best-selling triple-agonist research peptide", and its "product page identifies its product as LY3437943".[7]
- Promotions. A TikTok video advertised "BUY ONE GET ONE FREE RETA, TIRZ, SEMA," and more. Lilly also points to a subscribe-and-save "program (up to 15% off)", military discounts, and "discreet packaging with no identifying labels".[7] The About page says "Plain boxes, no identifying labels".[5]
- Wholesale. The wholesale form targets "Research laboratories, Medical clinics," compounding pharmacies, universities and resellers.[7]
The only document on the public docket is the complaint. As of 18 November 2026 no lawyer has appeared for the defendant.[28]
Research use only. The site says its products are for research use only on every page. The gate asks the visitor to tick "I am 21+ and a qualified researcher purchasing solely for in vitro laboratory research", and it offers "20% off your first order" for doing so.[8] The About page describes peptides "for in vitro and in vivo research", that is, research in living organisms as well.[5] Lilly quotes an earlier version of the gate asking for "a qualified research professional aged 21 or older".[7]
FDA. On 18 November 2026 we searched FDA's warning-letter index for "American Peptides" and found no letter.[29]
Age. In April the gate was a one-click box: a 21-and-over notice with Accept and Decline buttons, shown in the first picture's capture.[2] The later gate is the one quoted above.
Payment. Subscriptions are billed "typically every 60 days" through a processor the policy names, "TagadaPay". Once a billing has run, "The already-processed order will ship as scheduled and is non-refundable". Refunds are limited to damage, shipping errors and "products that fail independent purity verification".[30] The April storefront said "we offer refunds only for damaged or incorrect shipments".[2]
Still open
- Who owns it. The complaint names a Wyoming LLC and its organizer. We found no state record of who owns it, and the site names no person.
- Where it is made. The April About page said the raw peptides come from abroad. The October pages say manufactured domestically and name one US lab, without a name. We found no registration or inspection record behind either.
- The certificates. The laboratory's portal serves a later version of both retatrutide certificates, with a sterility result added. Neither the store nor the laboratory says why, and we have not asked them.
Changes
2026-11-18: first published. Later the same day: the store's certificates compared with the laboratory's own copies (Lab results, Still open).
References
- RDAP record for americanpeptides.us (registered 2026-02-21, registrant redacted), read 2026-11-18 — Registry Services for .us
- americanpeptides.us home page, archived 2026-04-07 — Wayback Machine
- americanpeptides.us, About, archived 2026-04-07 — Wayback Machine
- americanpeptides.us, Contact, archived 2026-10-11 — Wayback Machine
- americanpeptides.us, About, archived 2026-10-12 — Wayback Machine
- americanpeptides.us home page, archived 2026-11-03 — Wayback Machine
- Eli Lilly and Company v. American Peptides LLC d/b/a American Peptides, No. 5:26-cv-04146 (W.D. La.), complaint (ECF 1), filed 2026-10-08 — US District Court, W.D. La., via CourtListener RECAP
- americanpeptides.us home page, archived 2026-10-06 — Wayback Machine
- americanpeptides.us home page, archived 2026-10-09 — Wayback Machine
- americanpeptides.us home page, archived 2026-10-11 — Wayback Machine
- americanpeptides.us, Wholesale, archived 2026-10-05 — Wayback Machine
- americanpeptides.us, Partner Program, archived 2026-10-08 — Wayback Machine
- r/Peptides posts 2025-09-01 to 2026-11-18 (18,427) and r/Retatrutide posts 2026-06-07 to 2026-11-18 (20,000), through the Arctic Shift archive, searched for 'american peptides' on 2026-11-18: 10 threads — Arctic Shift — anecdotal report, not evidence
- Reta 60mg (2026-08-20) — r/Retatrutide — anecdotal report, not evidence
- Sourcing? (2026-10-18) — r/Peptides — anecdotal report, not evidence
- American Peps (2026-09-22) — r/Retatrutide — anecdotal report, not evidence
- Reta legit? (2026-09-22) — r/Retatrutide — anecdotal report, not evidence
- Help with reconstituting the lyophilized powder (2026-11-15) — r/Retatrutide — anecdotal report, not evidence
- americanpeptides.us, Certificates of Analysis, archived 2026-10-10 — Wayback Machine
- Certificate of analysis COA5633, Retatrutide 48 mg, lot RETA48-0616, Bioviridian Inc., issued 2026-06-25, as published by the store (archived 2026-08-13) — Wayback Machine
- Certificate of analysis COA7580, Retatrutide 10 mg, lot RETA10-0803, Bioviridian Inc., issued 2026-08-17, as published by the store (archived 2026-10-07) — Wayback Machine
- Certificate of analysis COA3362, AOD-9604 5 mg, lot AOD5-0318, Bioviridian Inc., issued 2026-04-03, as published by the store (archived 2026-08-13) — Wayback Machine
- Bioviridian Inc., COA Search (read 2026-11-18) — Bioviridian Inc.
- Certificate of analysis COA3362, AOD-9604, as the laboratory's portal serves it on 2026-11-18 (byte-identical to the copy the store published) — Bioviridian Inc.
- Certificate of analysis COA5633, Retatrutide 48mg, lot RETA48-0616, as the laboratory's portal serves it on 2026-11-18 (COA issued July 7, 2026; image-only PDF) — Bioviridian Inc.
- Certificate of analysis COA7580, lot RETA10-0803, as the laboratory's portal serves it on 2026-11-18 (COA issued August 28, 2026; sample name Retatrutide 100mg; image-only PDF) — Bioviridian Inc.
- Bioviridian Inc., Services (read 2026-11-18) — Bioviridian Inc.
- Docket, Eli Lilly & Co v. American Peptides L L C, 5:26-cv-04146 (W.D. La.); RECAP document store checked 2026-11-18 (the complaint only) — CourtListener (RECAP)
- FDA warning-letter index searched for 'american peptides', 2026-11-18 (no results; the same query for 'peptide partners' returns one letter) — U.S. Food and Drug Administration
- americanpeptides.us, Cancellation Policy, archived 2026-10-12 — Wayback Machine
Comments
Sign in to join the conversation.
No comments yet.